Based on our study, further discovery of the systematic molecular mechanisms that how S100 interacts with different signaling and other molecules or leads to different prognosis of ovarian cancer patients can pave a way for more effective tumor diagnosis and serve as a genetic treatment target. This evidence concerns the gene S100A1 and neoplasm.